3 progressive MS patients see lowered disability with CAR T-cell therapy
After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking and hand function.| Multiple Sclerosis News Today
After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking and hand function.| Multiple Sclerosis News Today
The Advanced Research Projects Agency for Health (ARPA-H) supports transformative research to drive biomedical and health breakthroughs ranging from molecular to societal to provide transformative health solutions for all.| ARPA-H
Marisa Wexler is a senior science writer for Multiple Sclerosis News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of multiple sclerosis topics.| Multiple Sclerosis News Today
Category archive page for News.| Multiple Sclerosis News Today
The exact causes of MS are not known, but several factors, such as genetic factors, infection, and demographics, are linked to MS development.| Multiple Sclerosis News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today
